Home > News > Top Stories > Takeda and MMV launch new programme to find lead compounds for malaria treatment

Takeda and MMV launch new programme to find lead compounds for malaria treatment

Japanese-based Takeda Pharmaceutical Company and Medicines for Malaria Venture in Switzerland (MMV) have signed an agreement to start a new joint research programme aimed at finding lead compounds for malaria treatment.

Spotlight

More featured news

Spotlight

Related News

Read More

Read More

Read More

More featured news